{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:59:38Z","timestamp":1792623578594,"version":"4.5.0"},"reference-count":217,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T00:00:00Z","timestamp":1676073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Matrix metalloproteinases (MMPs) are endopeptidases participating in physiological processes of the brain, maintaining the blood\u2013brain barrier integrity and playing a critical role in cerebral ischemia. In the acute phase of stroke activity, the expression of MMPs increase and is associated with adverse effects, but in the post-stroke phase, MMPs contribute to the process of healing by remodeling tissue lesions. The imbalance between MMPs and their inhibitors results in excessive fibrosis associated with the enhanced risk of atrial fibrillation (AF), which is the main cause of cardioembolic strokes. MMPs activity disturbances were observed in the development of hypertension, diabetes, heart failure and vascular disease enclosed in CHA2DS2VASc score, the scale commonly used to evaluate the risk of thromboembolic complications risk in AF patients. MMPs involved in hemorrhagic complications of stroke and activated by reperfusion therapy may also worsen the stroke outcome. In the present review, we briefly summarize the role of MMPs in the ischemic stroke with particular consideration of the cardioembolic stroke and its complications. Moreover, we discuss the genetic background, regulation pathways, clinical risk factors and impact of MMPs on the clinical outcome.<\/jats:p>","DOI":"10.3390\/ijms24043628","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T03:28:46Z","timestamp":1676258926000},"page":"3628","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Matrix Metalloproteinases in Cardioembolic Stroke: From Background to Complications"],"prefix":"10.3390","volume":"24","author":[{"given":"Anna","family":"Wysocka","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Internal Nursing, Faculty of Health Sciences, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3157-2824","authenticated-orcid":false,"given":"Jacek","family":"Szczygielski","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Institute of Medical Sciences, University of Rzesz\u00f3w, 35-310 Rzesz\u00f3w, Poland"},{"name":"Department of Neurosurgery, Saarland University Medical Center, Saarland University Faculty of Medicine, 66421 Homburg, Saar, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Kopa\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Physiology, Institute of Medical Sciences, University of Rzesz\u00f3w, 35-310 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim M.","family":"Oertel","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Saarland University Medical Center, Saarland University Faculty of Medicine, 66421 Homburg, Saar, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5398-4179","authenticated-orcid":false,"given":"Andrzej","family":"G\u0142owniak","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical University of Lublin, 20-954 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry","volume":"92","author":"Visse","year":"2003","journal-title":"Circ. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00726-010-0689-x","article-title":"Physiology and pathophysiology of matrix metalloproteases","volume":"41","author":"Klein","year":"2011","journal-title":"Amino Acids"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"6927328","DOI":"10.1155\/2016\/6927328","article-title":"Oxidative DNA damage mediated by intracellular MMP activity is associated with neuronal apoptosis in ischemic stroke","volume":"2016","author":"Yang","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Laronha, H., and Caldeira, J. (2020). Structure and Function of Human Matrix Metalloproteinases. Cells, 9.","DOI":"10.3390\/cells9051076"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","article-title":"Biochemical and Biological Attributes of Matrix Metalloproteinases","volume":"147","author":"Cui","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"ref_7","first-page":"3238165","article-title":"Stroke in the 21st Century: A Snapshot of the Burden, Epidemiology, and Quality of Life","volume":"2018","author":"Donkor","year":"2018","journal-title":"Stroke Res. Treat."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1160\/TH16-11-0876","article-title":"Stroke prevention in atrial fibrillation: Past, present and future. Comparing the guidelines and practical decision-making","volume":"117","author":"Lip","year":"2017","journal-title":"Thromb. Haemost."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/europace\/euq350","article-title":"Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"12","author":"Camm","year":"2010","journal-title":"Europace"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e012697","DOI":"10.1161\/JAHA.119.012697","article-title":"Identification of Markers Associated with Development of Stroke in \u201cClinically Low-Risk\u201d Atrial Fibrillation Patients","volume":"821","author":"Shin","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.biochi.2004.11.019","article-title":"Crystal structures of MMPs in complex with physiological and pharmacological inhibitors","volume":"87","author":"Maskos","year":"2005","journal-title":"Biochimie"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/bs.pmbts.2017.04.003","article-title":"Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders","volume":"148","author":"Liu","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbamcr.2009.04.003","article-title":"Matrix metalloproteinases: Fold and function of their catalytic domains","volume":"1803","author":"Tallant","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/j.bmc.2007.01.011","article-title":"Matrix metalloproteinases (MMPs): Chemical-biological functions and (Q)SARs","volume":"15","author":"Verma","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.mam.2008.05.002","article-title":"Progress in matrix metalloproteinase research","volume":"29","author":"Murphy","year":"2008","journal-title":"Mol. Asp. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbamcr.2009.08.006","article-title":"To bind zinc or not to bind zinc: An examination of innovative approaches to improved metalloproteinase inhibition","volume":"1803","author":"Jacobsen","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Rangasamy, L., Geronimo, B.D., Ort\u00edn, I., Coderch, C., Zapico, J.M., Ramos, A., and de Pascual-Teresa, B. (2019). Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs). Molecules, 24.","DOI":"10.3390\/molecules24162982"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"D239","DOI":"10.1093\/nar\/gkn570","article-title":"The Degredomedatabase: Mammalian proteases and diseases of proteolysis","volume":"37","author":"Quesada","year":"2009","journal-title":"Acids Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.2174\/0929867325666180326163523","article-title":"Mechanism and Inhibition of Matrix Metalloproteinases","volume":"26","author":"Cerofolini","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.biocel.2007.12.006","article-title":"The regulation of matrix metaloproteinases and their inhibitors","volume":"40","author":"Clark","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11010-014-2068-5","article-title":"Platelet derived growth factor-BB induces matrix metalloproteinase-2 expression and rat vascular smooth muscle cell migration via ROCK and ERK\/p38 MAPK pathways","volume":"393","author":"Cui","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e00224","DOI":"10.1002\/phy2.224","article-title":"MMP-1 and MMP-9 regulate epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells","volume":"2","author":"Rao","year":"2014","journal-title":"Physiol. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"521754","DOI":"10.1155\/2014\/521754","article-title":"Transforming growth factor-beta and matrix metalloproteinases: Functional interactions in tumor stroma-infiltrating myeloid cells","volume":"2014","author":"Krstic","year":"2014","journal-title":"Sci. World J."},{"key":"ref_25","first-page":"9331","article-title":"Co-recycling of MT1-MMP and MT3-MMP through the trans-Golgi network","volume":"279","author":"Wang","year":"2004","journal-title":"Identification of DKV582 as a recycling signal. J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1161\/CIRCULATIONAHA.104.502617","article-title":"Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinasepro-matrix metalloproteinase-2 proteolytic cascade in atherosclerosis","volume":"111","author":"Stawowy","year":"2005","journal-title":"Circulation"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcp.20431","article-title":"MT1-MMP: A potent modifier of pericellular microenvironment","volume":"206","author":"Itoh","year":"2006","journal-title":"J. Cell. Physiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"17401","DOI":"10.1016\/S0021-9258(18)38172-9","article-title":"Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor","volume":"265","author":"Strickland","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"109993","DOI":"10.1016\/j.cellsig.2021.109993","article-title":"Reversion inducing cysteine rich protein with Kazal motifs and cardiovascular diseases: The RECKlessness of adverse remodeling","volume":"83","author":"Russell","year":"2021","journal-title":"Cell. Signal."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0092-8674(01)00597-9","article-title":"The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis","volume":"107","author":"Oh","year":"2001","journal-title":"Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1158\/0008-5472.CAN-08-2635","article-title":"RECK negatively regulates matrix metalloproteinase-9 transcription","volume":"69","author":"Takagi","year":"2009","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1074\/jbc.M806212200","article-title":"RECK forms cowbell-shaped dimers and inhibits matrix metalloproteinase-catalyzed cleavage of fibronectin","volume":"284","author":"Omura","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1038\/s41598-020-63338-4","article-title":"Analysis of the inhibiting activity of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) on matrix metalloproteinases","volume":"10","author":"Mendes","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0008-6363(02)00258-4","article-title":"Electrical, contractile and structural remodeling during atrial fibrillation","volume":"54","author":"Allessie","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s003950170065","article-title":"L-type calcium currents in atrial myocytes from patients with persistent and non-persistent atrial fibrillation","volume":"96","author":"Skasa","year":"2001","journal-title":"Basic Res. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fphys.2012.00214","article-title":"Fibrosis in Atrial Fibrillation\u2014Role of Reactive Species and MPO","volume":"3","author":"Friedrichs","year":"2012","journal-title":"Front. Physiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.15420\/aer.2021.51","article-title":"Atrial Fibrosis, Ischaemic Stroke and Atrial Fibrillation","volume":"10","author":"Mahnkopf","year":"2021","journal-title":"Arrhythm. Electrophysiol. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Sygitowicz, G., Maciejak-Jastrz\u0119bska, A., and Sitkiewicz, D. (2021). A Review of the Molecular Mechanisms Underlying Cardiac Fibrosis and Atrial Fibrillation. J. Clin. Med., 10.","DOI":"10.3390\/jcm10194430"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCRESAHA.120.316363","article-title":"Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective","volume":"127","author":"Nattel","year":"2020","journal-title":"Circ. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.hrthm.2018.07.019","article-title":"Structural remodeling and conduction velocity dynamics in the human left atrium: Relationship with reentrant mechanisms sustaining atrial fibrillation","volume":"16","author":"Honarbakhsh","year":"2019","journal-title":"Heart Rhythm."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0735-1097(03)00585-0","article-title":"Matrix metalloproteinases and atrial structural remodeling","volume":"42","author":"Hoit","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Hsiao, F.C., Yeh, Y.H., Chen, W.J., Chan, Y.H., Kuo, C.T., Wang, C.L., Chang, C.J., Tsai, H.Y., Tsai, F.C., and Hsu, L.A. (2016). MMP9 Rs3918242 Polymorphism Affects Tachycardia-Induced MMP9 Expression in Cultured Atrial-Derived Myocytes but Is Not a Risk Factor for Atrial Fibrillation among the Taiwanese. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17040521"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cca.2010.02.002","article-title":"MMP-2 and TIMP-2 gene polymorphisms and susceptibility to atrial fibrillation in Chinese Han patients with hypertensive heart disease","volume":"411","author":"Gai","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cca.2009.07.020","article-title":"Association of MMP-9 gene polymorphisms with atrial fibrillation in hypertensive heart disease patients","volume":"408","author":"Gai","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2459\/JCM.0b013e3283403366","article-title":"MMP-1 and MMP-3 polymorphism and arrhythmia recurrence after electrical cardioversion in patients with persistent atrial fibrillation","volume":"12","author":"Lombardi","year":"2011","journal-title":"J. Cardiovasc. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"17517","DOI":"10.1038\/s41598-017-17537-1","article-title":"The \u03b2-fibrinogen gene 455G\/A polymorphism associated with cardioembolic stroke in atrial fibrillation with low CHA2DS2-VaSc score","volume":"7","author":"Hu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"10543","DOI":"10.1111\/jcmm.16985","article-title":"MicroRNA-146b-5p promotes atrial fibrosis in atrial fibrillation by repressing TIMP4","volume":"25","author":"Ye","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jacc.2008.03.045","article-title":"Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: Biochemical assessment of collagen type-I turnover","volume":"52","author":"Kallergis","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ancard.2014.12.004","article-title":"MMP-9 in atrial remodeling in patients with atrial fibrillation","volume":"64","author":"Lewkowicz","year":"2015","journal-title":"Ann. Cardiol. Angeiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cyto.2017.12.026","article-title":"The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation","volume":"103","author":"Stanciu","year":"2018","journal-title":"Cytokine"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jtcvs.2019.02.068","article-title":"Atrial contractility and fibrotic biomarkers are associated with atrial fibrillation after elective coronary artery bypass grafting","volume":"159","author":"Bening","year":"2020","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1582-4934.2008.00219.x","article-title":"Atrial extracellular matrix remodelling in patients with atrial fibrillation","volume":"12","author":"Polyakova","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/europace\/euw335","article-title":"Association of pre-ablation level of potential blood markers with atrial fibrillation recurrence after catheter ablation: A meta-analysis","volume":"19","author":"Jiang","year":"2017","journal-title":"Europace"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cjca.2015.08.001","article-title":"Association of MMPs and TIMPs With the Occurrence of Atrial Fibrillation: A Systematic Review and Meta-analysis","volume":"32","author":"Liu","year":"2016","journal-title":"Can. J. Cardiol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Huxley, R.R., Lopez, F.L., MacLehose, R.F., Eckfeldt, J.H., Couper, D., Leiendecker-Foster, C., Hoogeveen, R.C., Chen, L.Y., Soliman, E.Z., and Agarwal, S.K. (2013). Novel association between plasma matrix metalloproteinase-9 and risk of incident atrial fibrillation in a case-cohort study: The Atherosclerosis Risk in Communities study. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059052"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/bs.pmbts.2017.02.001","article-title":"Matrix Metalloproteinases in Myocardial Infarction and Heart Failure","volume":"147","author":"Meschiari","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"15575","DOI":"10.1073\/pnas.0506201102","article-title":"Divergent efects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries","volume":"102","author":"Johnson","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/cvr\/cvv268","article-title":"Diferential efects of tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 on atherosclerosis and monocyte\/macrophage invasion","volume":"109","author":"George","year":"2016","journal-title":"Cardiovasc. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"23081","DOI":"10.1038\/s41598-021-02508-4","article-title":"Disparate effects of MMP and TIMP modulation on coronary atherosclerosis and associated myocardial fibrosis","volume":"11","author":"Kremastiotis","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1755-5922.2010.00207.x","article-title":"Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction","volume":"30","author":"Lindsey","year":"2012","journal-title":"Cardiovasc. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1573403X15666190509090832","article-title":"Regulation of Myocardial Extracellular Matrix Dynamic Changes in Myocardial Infarction and Postinfarct Remodeling","volume":"16","author":"Ushakov","year":"2020","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1161\/CIRCULATIONAHA.106.612960","article-title":"Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction","volume":"113","author":"Lindsey","year":"2006","journal-title":"Circulation"},{"key":"ref_63","first-page":"297","article-title":"Correlation between acute myocardial infarction complicated with cerebral infarction and expression levels of MMP-2 and MMP-9","volume":"23","author":"Zhou","year":"2019","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12041-009-0035-9","article-title":"Association of matrix metalloproteinase-2 gene promoter polymorphism with myocardial infarction susceptibility in a Mexican population","volume":"88","year":"2009","journal-title":"J. Genet."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e22218","DOI":"10.1002\/jcla.22218","article-title":"Association of R279Q and C1562T polymorphisms of matrix metalloproteinase 9 gene and increased risk for myocardial infarction in patients with premature coronary artery disease","volume":"32","author":"Sheikhvatan","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/1076029611412365","article-title":"Interaction between MMP-9 gene polymorphisms and smoking in relation to myocardial infarction in a Uighur population","volume":"18","author":"Wang","year":"2012","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Opstad, T.B., Arnesen, H., Pettersen, A.\u00c5., and Seljeflot, I. (2014). The MMP-9 -1562 C\/T polymorphism in the presence of metabolic syndrome increases the risk of clinical events in patients with coronary artery disease. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0106816"},{"key":"ref_68","first-page":"5507153","article-title":"Genetic Polymorphism of Matrix Metalloproteinase-9 and Susceptibility to Myocardial Infarction: A Meta-Analysis","volume":"2022","author":"Feng","year":"2022","journal-title":"Dis. Mrk."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"718","DOI":"10.5551\/jat.11817","article-title":"The matrix metalloproteinase 2-1575 gene polymorphism is associated with the risk of developing myocardial infarction in Mexican patients","volume":"19","author":"Medina","year":"2012","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Ponikowska, B., Iwanek, G., Zdanowicz, A., Urban, S., Zymli\u0144ski, R., Ponikowski, P., and Biegus, J. (2022). Biomarkers of Myocardial Injury and Remodeling in Heart Failure. J. Pers. Med., 12.","DOI":"10.3390\/jpm12050799"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jacc.2015.07.035","article-title":"A Novel Collagen Matricryptin Reduces Left Ventricular Dilation Post-Myocardial Infarction by Promoting Scar Formation and Angiogenesis","volume":"66","author":"Lindsey","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Beber, A.R., Polina, E.R., Biolo, A., Santos, B.L., Gomes, D.C., La Porta, V.L., Olsen, V., Clausell, N., Rohde, L.E., and Santos, K.G. (2016). Matrix Metalloproteinase-2 Polymorphisms in Chronic Heart Failure: Relationship with Susceptibility and Long-Term Survival. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0161666"},{"key":"ref_73","first-page":"1299","article-title":"Two MMP-2 promoter polymorphisms (-790T\/G and -735C\/T) in chronic heart failure","volume":"41","author":"Spinar","year":"2003","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ehj.2004.01.015","article-title":"Prognostic impact of matrix metalloproteinase gene polymorphisms in patients with heart failure according to the aetiology of left ventricular systolic dysfunction","volume":"25","author":"Lamblin","year":"2004","journal-title":"Eur. Heart J."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Prado, A.F., Batista, R.I.M., Tanus-Santos, J.E., and Gerlach, R.F. (2021). Matrix Metalloproteinases and Arterial Hypertension: Role of Oxidative Stress and Nitric Oxide in Vascular Functional and Structural Alterations. Biomolecules, 11.","DOI":"10.3390\/biom11040585"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.matbio.2009.11.005","article-title":"Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling","volume":"29","author":"Castro","year":"2010","journal-title":"Matrix Biol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/bcpt.12787","article-title":"Matrix Metalloproteinase-2 Activity is Associated with Divergent Regulation of Calponin-1 in Conductance and Resistance Arteries in Hypertension-induced Early Vascular Dysfunction and Remodelling","volume":"121","author":"Parente","year":"2017","journal-title":"Basic Clin. Pharm. Toxicol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/cvr\/cvx115","article-title":"Matrix metalloproteinase-2 knockout prevents angiotensin II-induced vascular injury","volume":"113","author":"Barhoumi","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/01.ATV.0000204344.90301.7c","article-title":"Vascular responses to alpha1-adrenergic receptors in small rat mesenteric arteries depend on mitochondrial reactive oxygen species","volume":"26","author":"Hao","year":"2006","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"H25","DOI":"10.1152\/ajpheart.00620.2009","article-title":"Matrix metalloproteinases cleave the beta2-adrenergic receptor in spontaneously hypertensive rats","volume":"299","author":"Rodrigues","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0167-5273(00)00274-6","article-title":"Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy","volume":"75","author":"Edmunds","year":"2000","journal-title":"Int. J. Cardiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0895-7061(04)00855-6","article-title":"Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)","volume":"17","author":"Tayebjee","year":"2004","journal-title":"Am. J. Hypertens."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"760","DOI":"10.5114\/aoms.2016.58825","article-title":"The effect of antihypertensive treatment on arterial stiffness and serum concentration of selected matrix metalloproteinases","volume":"13","author":"Rajzer","year":"2017","journal-title":"Arch. Med. Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/sj.jhh.1002244","article-title":"Matrix metalloproteinase-9 polymorphism contributes to blood pressure and arterial stiffness in essential hypertension","volume":"21","author":"Zhou","year":"2007","journal-title":"J. Hum. Hypertens."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/IBPC.S223341","article-title":"Matrix Metalloproteinases and Hypertension-Mediated Organ Damage: Current Insights","volume":"13","author":"Bisogni","year":"2020","journal-title":"Integr. Blood Press Control"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0b013e32834d249a","article-title":"Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: A systematic review and meta-analysis","volume":"30","author":"Marchesi","year":"2012","journal-title":"J. Hypertens."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/CIRCHEARTFAILURE.110.958199","article-title":"Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure","volume":"4","author":"Zile","year":"2011","journal-title":"Circ. Heart Fail."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Cheng, Z., Limbu, M.H., Wang, Z., Liu, J., Liu, L., Zhang, X., Chen, P., and Liu, B. (2017). MMP-2 and 9 in Chronic Kidney Disease. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18040776"},{"key":"ref_89","first-page":"198","article-title":"MMP-9 Levels and IMT of Carotid Arteries are Elevated in Obese Children and Adolescents Compared to Non-Obese","volume":"108","author":"Andrade","year":"2017","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/1354750X.2013.866165","article-title":"Serum levels and polymorphisms of matrix metalloproteinases (MMPs) in carotid artery atherosclerosis: Higher MMP-9 levels are associated with plaque vulnerability","volume":"19","author":"Silvello","year":"2014","journal-title":"Biomarkers"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/ATVBAHA.115.305631","article-title":"Elevated Plasma Levels of MMP-12 Are Associated with Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects with Type 2 Diabetes","volume":"35","author":"Goncalves","year":"2015","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Gajewska, B., and \u015aliwi\u0144ska-Mosso\u0144, M. (2022). Association of MMP-2 and MMP-9 Polymorphisms with Diabetes and Pathogenesis of Diabetic Complications. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231810571"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"107908","DOI":"10.1016\/j.jdiacomp.2021.107908","article-title":"Association of matrix metalloproteinase-2 gene polymorphisms with susceptibility to type 2 diabetes: A case control study","volume":"35","author":"Sarray","year":"2021","journal-title":"J. Diabetes Complicat."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/1534734613493289","article-title":"A Functional Single Nucleotide Polymorphism -1562C>T in the Matrix Metalloproteinase-9 Promoter Is Associated with Type 2 Diabetes and Diabetic Foot Ulcers","volume":"12","author":"Singh","year":"2013","journal-title":"Int. J. Low. Extrem. Wounds"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3892\/br.2017.856","article-title":"Association of COL4A3 (Rs55703767), MMP-9 (Rs17576) and TIMP-1 (Rs6609533) gene polymorphisms with susceptibility to type 2 diabetes","volume":"6","author":"Saravani","year":"2017","journal-title":"Biomed. Rep."},{"key":"ref_96","first-page":"2583","article-title":"Matrix metalloproteases as a pharmacological target in cardiovascular diseases","volume":"19","author":"Hopps","year":"2015","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eur002","article-title":"Upstream therapies for management of atrial fibrillation: Review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: Primary prevention","volume":"13","author":"Savelieva","year":"2011","journal-title":"Europace"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.cardfail.2008.07.229","article-title":"Matrix metalloproteinase inhibition attenuates atrial remodeling and vulnerability to atrial fibrillation in a canine model of heart failure","volume":"14","author":"Moe","year":"2008","journal-title":"J. Card. Fail."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.phrs.2011.04.002","article-title":"Matrix metalloproteinases: Targets for doxycycline to prevent the vascular alterations of hypertension","volume":"64","author":"Castro","year":"2011","journal-title":"Pharm. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e918883","DOI":"10.12659\/MSM.918883","article-title":"Doxycycline Improves Fibrosis-Induced Abnormalities in Atrial Conduction and Vulnerability to Atrial Fibrillation in Chronic Intermittent Hypoxia Rats","volume":"26","author":"Ma","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00059-018-4768-1","article-title":"Effect of doxycycline on chronic intermittent hypoxia-induced atrial remodeling in rats","volume":"45","author":"Zhang","year":"2020","journal-title":"Herz"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"H543","DOI":"10.1152\/ajpheart.2001.281.2.H543","article-title":"Matrix metalloproteinase expression and activity in isolated myocytes after neurohormonal stimulation","volume":"281","author":"Coker","year":"2001","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"590","DOI":"10.5551\/jat.3624","article-title":"Blockade of renin-angiotensin system attenuates advanced glycation end products-mediated signaling pathways","volume":"17","author":"Kamioka","year":"2010","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejim.2008.10.003","article-title":"Serum levels of MMP-9 and TIMP-1 in primary hypertension and effect of antihypertensive treatment","volume":"20","author":"Onal","year":"2009","journal-title":"Eur. J. Intern. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jacc.2004.03.065","article-title":"Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease","volume":"44","author":"Schieffer","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s00380-010-0013-4","article-title":"Effects of telmisartan on markers of ventricular remodeling in patients with acute myocardial infarction: Comparison with enalapril","volume":"25","author":"Yokota","year":"2010","journal-title":"Heart Vessel."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1253\/circj.CJ-09-0412","article-title":"Changes of matrix metalloproteinase-9 level is associated with left ventricular remodeling following acute myocardial infarction among patients treated with trandolapril, valsartan or both","volume":"74","author":"Miyazaki","year":"2010","journal-title":"Circ. J."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1074\/jbc.M113.519256","article-title":"The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation","volume":"289","author":"Lavall","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1016\/j.ijcard.2013.08.022","article-title":"Impact of aldosterone antagonists on the substrate for atrial fibrillation: Aldosterone promotes oxidative stress and atrial structural\/electrical remodeling","volume":"168","author":"Mayyas","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1476-5381.2010.00675.x","article-title":"Aldosterone-receptor antagonism as a potential therapeutic option for atrial fibrillation","volume":"159","author":"Lendeckel","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/j.1476-5381.2009.00551.x","article-title":"Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing","volume":"159","author":"Zhao","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0828-282X(09)70138-2","article-title":"Treatment with spironolactone for 24 weeks decreases the level of matrix metalloproteinases and improves cardiac function in patients with chronic heart failure of ischemic etiology","volume":"25","author":"Li","year":"2009","journal-title":"Can. J. Cardiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jchf.2020.11.010","article-title":"Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF","volume":"9","author":"Ferreira","year":"2021","journal-title":"JACC Heart Fail."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1097\/HJH.0b013e328364abd6","article-title":"Eplerenone enhances cardioprotective effects of standard heart failure therapy through matricellular proteins in hypertensive heart failure","volume":"31","author":"Aragoncillo","year":"2013","journal-title":"J. Hypertens."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"9494981","DOI":"10.1155\/2022\/9494981","article-title":"The Difference between Sacubitril Valsartan and Valsartan on Vascular Endothelial Function, APN, MMP-9, and BNP Levels in Patients with Hypertension and Chronic Heart Failure","volume":"2022","author":"Du","year":"2022","journal-title":"J. Health Eng."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jacc.2018.11.042","article-title":"Effects of Sacubitril\/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients with HFrEF","volume":"73","author":"Zile","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"4164089","DOI":"10.1155\/2022\/4164089","article-title":"Clinical Study of Heart Failure with Left Ventricular Ejection Fraction Regimen Treated with Entresto","volume":"2022","author":"Feng","year":"2022","journal-title":"Contrast Media Mol. Imaging"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacc.2011.11.063","article-title":"Eplerenone and atrial fibrillation in mild systolic heart failure: Results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization and SurvIval Study in Heart Failure) study","volume":"59","author":"Swedberg","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejvs.2003.09.014","article-title":"The role of statins in vascular disease","volume":"27","author":"Laws","year":"2004","journal-title":"Eur. J. Vasc. Endovasc Surg."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/aps.2010.109","article-title":"Simvastatin inhibited cardiac hypertrophy and fibrosis in apolipoprotein E-deficient mice fed a \u201cWestern-style diet\u201d by increasing PPAR \u03b1 and \u03b3 expression and reducing TC, MMP-9, and Cat S levels","volume":"31","author":"Qin","year":"2010","journal-title":"Acta Pharm. Sin."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.arcmed.2009.07.006","article-title":"Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice","volume":"40","author":"Guo","year":"2009","journal-title":"Arch. Med. Res."},{"key":"ref_123","first-page":"454","article-title":"Atorvastatin treatment decreases inflammatory and proteolytic activity in patients with hypercholesterolemia","volume":"60","author":"Ercan","year":"2004","journal-title":"Kardiol. Pol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s11095-008-9798-6","article-title":"Effect of atorvastatin versus rosuvastatin on levels of serum lipids, inflammatory markers and adiponectin in patients with hypercholesterolemia","volume":"26","author":"Qu","year":"2009","journal-title":"Pharm. Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijcard.2003.09.007","article-title":"Comparative effects of statin and fibrate on nitric oxide bioactivity and matrix metalloproteinase in hyperlipidemia","volume":"97","author":"Koh","year":"2004","journal-title":"Int. J. Cardiol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ahj.2007.07.015","article-title":"Statin use and recurrence of atrial fibrillation after successful cardioversion","volume":"154","author":"Humphries","year":"2007","journal-title":"Am. Heart J."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/0271678X16655551","article-title":"Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers","volume":"36","author":"Rempe","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/jnen\/63.4.338","article-title":"Activation of matrix metalloproteinase-3 and agrin cleavage in cerebral ischemia\/reperfusion","volume":"63","author":"Petegnief","year":"2004","journal-title":"Neuropathol. Exp. Neurol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jnr.10270","article-title":"Extracellular proteolysis in brain injury and inflammation: Role for plasminogen activators and matrix metalloproteinases","volume":"69","author":"Lo","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/01.STR.0000223001.06264.af","article-title":"Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke","volume":"37","author":"Rosell","year":"2006","journal-title":"Stroke"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000087197","article-title":"Matrix metalloproteinases in cerebrovascular diseases","volume":"20","author":"Fatar","year":"2005","journal-title":"Cereb. Dis."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3109\/00207454.2013.872102","article-title":"The significance of matrix metalloproteinase (MMP)-2 and MMP-9 in the ischemic stroke","volume":"124","author":"Kurzepa","year":"2014","journal-title":"Int. J. Neurosci."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0304-3940(97)00859-8","article-title":"Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia","volume":"238","author":"Clark","year":"1997","journal-title":"Neurosci. Lett."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1749-6632.2010.05734.x","article-title":"Metalloproteinase and stroke infarct size: Role for anti-inflammatory treatment?","volume":"1207","author":"Morancho","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1326-7-21","article-title":"Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia","volume":"7","author":"Cui","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2018.02.012","article-title":"Serum matrix metalloproteinase-8, tissue inhibitor of metalloproteinase and myeloperoxidase in ischemic stroke","volume":"271","author":"Palm","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/01.CIR.0000058700.41738.12","article-title":"Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease","volume":"107","author":"Blankenberg","year":"2003","journal-title":"Circulation"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.atherosclerosis.2012.05.031","article-title":"Sex-specific effect of matrix metalloproteinase-9 functional promoter polymorphism on carotid artery stiffness","volume":"223","author":"Lin","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_139","first-page":"400","article-title":"Correlations between MMP-2\/MMP-9 promoter polymorphisms and ischemic stroke","volume":"7","author":"Nie","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s12017-015-8367-5","article-title":"Matrix Metalloproteinase-9 (MMP-9) Gene Polymorphism in Stroke Patients","volume":"17","author":"Buraczynska","year":"2015","journal-title":"Neuromolecular. Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"19418","DOI":"10.4238\/2015.December.30.3","article-title":"Associations between matrix metalloproteinase gene polymorphisms and the development of cerebral infarction","volume":"14","author":"Zhao","year":"2016","journal-title":"Genet. Mol. Res."},{"key":"ref_142","first-page":"11647","article-title":"Association between matrix metalloproteinase gene polymorphisms and development of ischemic stroke","volume":"8","author":"Hao","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"32","DOI":"10.21315\/mjms2021.28.6.4","article-title":"Matrix Metalloproteinase-9 Gene Polymorphism and Its Methylation in Stroke Patients","volume":"28","author":"Choudhari","year":"2021","journal-title":"Malays J. Med. Sci."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"6787","DOI":"10.1007\/s11033-014-3564-0","article-title":"Association between the MMP-9-1562 C>T polymorphism and the risk of stroke: A meta-analysis","volume":"41","author":"Fan","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"300060520926427","DOI":"10.1177\/0300060520926427","article-title":"Meta-analysis of matrix metalloproteinase (MMP)-9 C1562T polymorphism and susceptibility to ischemic stroke in the Chinese population","volume":"48","author":"Jiang","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.wneu.2019.08.026","article-title":"Influence of the Matrix Metalloproteinase 9 Gene rs3918242 Polymorphism on Development of Ischemic Stroke: A Meta-analysis","volume":"133","author":"Wu","year":"2020","journal-title":"World Neurosurg."},{"key":"ref_147","first-page":"949","article-title":"Relationship between the matrix metalloproteinase-9 gene polymorphisms and ischemic stroke","volume":"12","author":"Wang","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Gao, N., Guo, T., Luo, H., Tu, G., Niu, F., Yan, M., and Xia, Y. (2019). Association of the MMP-9 polymorphism and ischemic stroke risk in southern Chinese Han population. BMC Neurol., 19.","DOI":"10.1186\/s12883-019-1285-7"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"e01294","DOI":"10.1002\/brb3.1294","article-title":"Variants in matrix metalloproteinase-9 gene are associated with hemorrhagic transformation in acute ischemic stroke patients with atherothrombosis, small artery disease, and cardioembolic stroke","volume":"9","author":"Yi","year":"2019","journal-title":"Brain Behav."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"e01291","DOI":"10.1002\/brb3.1291","article-title":"Matrix metalloproteinase-9 gene polymorphisms are associated with ischemic stroke severity and early neurologic deterioration in patients with atrial fibrillation","volume":"9","author":"Yi","year":"2019","journal-title":"Brain Behav."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.atherosclerosis.2012.11.026","article-title":"A functional polymorphism at miR-491-5p binding site in the 3\u2019-UTR of MMP-9 gene confers increased risk for atherosclerotic cerebral infarction in a Chinese population","volume":"226","author":"Yuan","year":"2013","journal-title":"Atherosclerosis"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"e2473","DOI":"10.1002\/brb3.2473","article-title":"MMP9 SNP and MMP SNP-SNP interactions increase the risk for ischemic stroke in the Han Hakka population","volume":"12","author":"Fan","year":"2022","journal-title":"Brain Behav."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.08.021","article-title":"MMP Gene Polymorphisms, MMP-1 -1607 1G\/2G, -519 A\/G, and MMP-12 -82 A\/G, and Ischemic Stroke: A Meta-Analysis","volume":"27","author":"Zhang","year":"2018","journal-title":"J. Stroke Cereb. Dis."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.09.034","article-title":"Association of Matrix Metalloproteinase-1 and Matrix Metalloproteinase-3 Gene Variants with Ischemic Stroke and Its Subtype","volume":"26","author":"Huang","year":"2017","journal-title":"J. Stroke Cereb. Dis."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainres.2017.08.009","article-title":"Association of matrix metalloproteinase-3 gene 5A\/6A polymorphism with the recurrence of ischemic stroke: A prospective observational study","volume":"1674","author":"Huang","year":"2017","journal-title":"Brain Res."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.gene.2018.06.027","article-title":"Association between matrix metalloproteinase family gene polymorphisms and risk of ischemic stroke: A systematic review and meta-analysis of 29 studies","volume":"672","author":"Misra","year":"2018","journal-title":"Gene"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/hs0302.104542","article-title":"Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats","volume":"33","author":"Sumii","year":"2002","journal-title":"Stroke"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/00004647-200012000-00007","article-title":"Role for matrix metalloproteinase 9 after focal cerebral ischemia: Effects of gene knockout and enzyme inhibition with BB-94","volume":"20","author":"Asahi","year":"2000","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/jcbfm.2013.56","article-title":"Early inhibition of MMP activity in ischemic rat brain promotes expression of tight junction proteins and angiogenesis during recovery","volume":"33","author":"Yang","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.jcbfm.9600534","article-title":"Early beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brain","volume":"28","author":"Sood","year":"2008","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nm1387","article-title":"Role of matrix metalloproteinases in delayed cortical responses after stroke","volume":"12","author":"Zhao","year":"2006","journal-title":"Nat. Med."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Kim, E.H., Kim, E.S., Shin, D., Kim, D., Choi, S., Shin, Y.J., Kim, K.A., Noh, D., Caglayan, A.B., and Rajanikant, G.K. (2021). Carnosine Protects against Cerebral Ischemic Injury by Inhibiting Matrix-Metalloproteinases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147495"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"H87","DOI":"10.1152\/ajpheart.01206.2010","article-title":"Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats","volume":"301","author":"Pires","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Machado, L.S., Kozak, A., Ergul, A., Hess, D.C., Borlongan, C.V., and Fagan, S.C. (2006). Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neurosci., 7.","DOI":"10.1186\/1471-2202-7-56"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1161\/STROKEAHA.110.582601","article-title":"Minocycline to improve neurologic outcome in stroke (MINOS): A dose-finding study","volume":"41","author":"Fagan","year":"2010","journal-title":"Stroke"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/01.wnl.0000277487.04281.db","article-title":"Minocycline treatment in acute stroke: An open-label, evaluator-blinded study","volume":"69","author":"Lampl","year":"2007","journal-title":"Neurology"},{"key":"ref_167","first-page":"181","article-title":"Simvastatin could prevent increase of the serum MMP-9\/TIMP-1 ratio in acute ischaemic stroke","volume":"52","author":"Kurzepa","year":"2006","journal-title":"Folia Biol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1161\/STROKEAHA.111.000651","article-title":"Comparison of risk-scoring systems in predicting symptomatic intracerebral hemorrhage after intravenous thrombolysis","volume":"44","author":"Chen","year":"2013","journal-title":"Stroke"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/phar.2532","article-title":"TT genotype of the MMP-9-1562C\/T polymorphism may be a risk factor for thrombolytic therapy-induced hemorrhagic complications after acute ischemic stroke","volume":"41","author":"Jekic","year":"2021","journal-title":"Pharmacotherapy"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"703258","DOI":"10.3389\/fneur.2021.703258","article-title":"Hemorrhagic Transformation After Ischemic Stroke: Mechanisms and Management","volume":"12","author":"Hong","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1111\/ene.14985","article-title":"Blood-brain barrier leakage and hemorrhagic transformation: The Reperfusion Injury in Ischemic StroKe (RISK) study","volume":"28","author":"Arba","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1161\/01.STR.0000143219.16695.af","article-title":"Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke","volume":"35","author":"Wang","year":"2004","journal-title":"Stroke"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ibneur.2022.06.006","article-title":"Acute iron overload aggravates blood-brain barrier disruption and hemorrhagic transformation after transient focal ischemia in rats with hyperglycemia","volume":"13","author":"Wu","year":"2022","journal-title":"IBRO Neurosci. Rep."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1007\/s12035-022-02811-9","article-title":"GLP-1R Agonist Exendin-4 Protects Against Hemorrhagic Transformation Induced by rtPA After Ischemic Stroke via the Wnt\/\u03b2-Catenin Signaling Pathway","volume":"59","author":"Liu","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/jnr.24671","article-title":"Direct arterial damage and neurovascular unit disruption by mechanical thrombectomy in a rat stroke model","volume":"98","author":"Sasaki","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1189\/jlb.0907606","article-title":"Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release","volume":"84","author":"Cuadrado","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.expneurol.2006.01.032","article-title":"Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis","volume":"200","author":"Kelly","year":"2006","journal-title":"Exp Neurol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuroscience.2021.01.003","article-title":"Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke","volume":"460","author":"Saleem","year":"2021","journal-title":"Neuroscience"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1212\/WNL.0000000000004259","article-title":"Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: A meta-analysis","volume":"89","author":"Charidimou","year":"2017","journal-title":"Neurology"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/jcbfm.2013.203","article-title":"Hemorrhagic transformation after ischemic stroke in animals and humans","volume":"34","author":"Jickling","year":"2014","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fneur.2015.00121","article-title":"Unbalanced Metalloproteinase-9 and Tissue Inhibitors of Metalloproteinases Ratios Predict Hemorrhagic Transformation of Lesion in Ischemic Stroke Patients Treated with Thrombolysis: Results from the MAGIC Study","volume":"6","author":"Piccardi","year":"2015","journal-title":"Front. Neurol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1159\/000510804","article-title":"Biomarkers of Unfavorable Outcome in Acute Ischemic Stroke Patients with Successful Recanalization by Endovascular Thrombectomy","volume":"49","author":"Zang","year":"2020","journal-title":"Cereb. Dis."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/01.STR.0000046764.57344.31","article-title":"Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke","volume":"34","author":"Castellanos","year":"2003","journal-title":"Stroke"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.01.023","article-title":"The Accuracy of Serum Matrix Metalloproteinase-9 for Predicting Hemorrhagic Transformation After Acute Ischemic Stroke: A Systematic Review and Meta-Analysis","volume":"27","author":"Wang","year":"2018","journal-title":"J. Stroke Cereb. Dis."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1161\/STROKEAHA.106.481556","article-title":"Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: A multicenter confirmatory study","volume":"38","author":"Castellanos","year":"2007","journal-title":"Stroke"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/STROKEAHA.113.004627","article-title":"Fluid-attenuated inversion recovery hyperintensity correlates with matrix metalloproteinase-9 level and hemorrhagic transformation in acute ischemic stroke","volume":"45","author":"Jha","year":"2014","journal-title":"Stroke"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jnr.23302","article-title":"Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat","volume":"92","author":"Kono","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/STROKEAHA.114.005316","article-title":"Rivaroxaban and apixaban reduce hemorrhagic transformation after thrombolysis by protection of neurovascular unit in rat","volume":"45","author":"Kono","year":"2014","journal-title":"Stroke"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.04.002","article-title":"Effects of Pretreatment with Warfarin or Rivaroxaban on Neurovascular Unit Dissociation after Tissue Plasminogen Activator Thrombolysis in Ischemic Rat Brain","volume":"25","author":"Shang","year":"2016","journal-title":"J. Stroke Cereb. Dis."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1038\/s41598-018-25820-y","article-title":"Rivaroxaban does not influence hemorrhagic transformation in a diabetes ischemic stroke and endovascular thrombectomy model","volume":"8","author":"Liu","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/01.STR.32.5.1079","article-title":"Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke","volume":"32","author":"Molina","year":"2001","journal-title":"Stroke"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3389\/fneur.2020.00473","article-title":"Matrix Metalloproteinase-9 Relationship with Infarct Growth and Hemorrhagic Transformation in the Era of Thrombectomy","volume":"11","author":"Mechtouff","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Iwamoto, T., Kitano, T., Oyama, N., and Yagita, Y. (2021). Predicting hemorrhagic transformation after large vessel occlusion stroke in the era of mechanical thrombectomy. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0256170"},{"key":"ref_194","first-page":"11364","article-title":"Decompressive craniectomy can improve the recovery of neurological function, daily living ability and life quality of patients with intracerebral hemorrhage after surgery","volume":"13","author":"Ling","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jocn.2011.09.036","article-title":"The rs9509 polymorphism of MMP-9 is associated with risk of hemorrhage in brain arteriovenous malformations","volume":"19","author":"Sun","year":"2012","journal-title":"J. Clin. Neurosci."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jocn.2010.04.023","article-title":"The rs522616 polymorphism in the matrix metalloproteinase-3 (MMP-3) gene is associated with sporadic brain arteriovenous malformation in a Chinese population","volume":"17","author":"Zhao","year":"2010","journal-title":"J. Clin. Neurosci."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1161\/hs0901.095382","article-title":"Polymorphisms in matrix metalloproteinase-1, -3, -9, and -12 genes in relation to subarachnoid hemorrhage","volume":"32","author":"Zhang","year":"2001","journal-title":"Stroke"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0028-3843(14)60294-2","article-title":"Association between the -1562 C\/T MMP-9 polymorphism and cerebrovascular disease in a Polish population","volume":"44","author":"Szczudlik","year":"2010","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"15078","DOI":"10.1074\/jbc.M114.610931","article-title":"Sequential Amyloid-\u03b2 Degradation by the Matrix Metalloproteases MMP-2 and MMP-9","volume":"290","author":"Mawhirt","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1021\/bi901994d","article-title":"Degradation of soluble and fibrillar amyloid beta-protein by matrix metalloproteinase (MT1-MMP) in vitro","volume":"49","author":"Liao","year":"2010","journal-title":"Biochemistry"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"24566","DOI":"10.1074\/jbc.M602440200","article-title":"Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ","volume":"281","author":"Yan","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"27144","DOI":"10.1074\/jbc.M110.135228","article-title":"Matrix metalloproteinase 2 (MMP-2) degrades soluble vasculotropic amyloid-beta E22Q and L34V mutants, delaying their toxicity for human brain microvascular endothelial cells","volume":"285","author":"Mawhirt","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/jnr.22034","article-title":"Neuronal TIMP-1 release accompanies astrocytic MMP-9 secretion and enhances astrocyte proliferation induced by beta-amyloid 25-35 fragment","volume":"87","author":"Delgado","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/jnc.12028","article-title":"Nitric oxide-mediated regulation of \u03b2-amyloid clearance via alterations of MMP-9\/TIMP-1","volume":"123","author":"Ridnour","year":"2012","journal-title":"J. Neurochem."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ana.10671","article-title":"Matrix metalloproteinase-9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy","volume":"54","author":"Lee","year":"2003","journal-title":"Ann. Neurol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1161\/STROKEAHA.115.008582","article-title":"Minocycline reduces spontaneous hemorrhage in mouse models of cerebral amyloid angiopathy","volume":"46","author":"Yan","year":"2015","journal-title":"Stroke"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3233\/JAD-210288","article-title":"The Use of Serum Matrix Metalloproteinases in Cerebral Amyloid Angiopathy-Related Intracerebral Hemorrhage and Cognitive Impairment","volume":"82","author":"Xia","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/j.neurobiolaging.2015.07.016","article-title":"Matrix metalloproteinase 9-mediated intracerebral hemorrhage induced by cerebral amyloid angiopathy","volume":"36","author":"Zhao","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40478-020-00972-z","article-title":"Disturbed balance in the expression of MMP9 and TIMP3 in cerebral amyloid angiopathy-related intracerebral haemorrhage","volume":"8","author":"Kuiperij","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/STROKEAHA.109.556852","article-title":"Minocycline and tissue-type plasminogen activator for stroke: Assessment of interaction potential","volume":"40","author":"Machado","year":"2009","journal-title":"Stroke"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1161\/STROKEAHA.108.514026","article-title":"Extension of the thrombolytic time window with minocycline in experimental stroke","volume":"39","author":"Murata","year":"2008","journal-title":"Stroke"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.brainres.2007.10.052","article-title":"Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat: Effects on BBB breakdown and MMP expression in the acute and subacute phase","volume":"1188","author":"Nagel","year":"2008","journal-title":"Brain Res."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2147\/NDT.S199371","article-title":"Simvastatin pretreatment ameliorates t-PA-induced hemorrhage transformation and MMP-9\/TIMP-1 imbalance in thromboembolic cerebral ischemic rats","volume":"15","author":"Yin","year":"2019","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1007\/s11064-013-1185-y","article-title":"Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic stroke","volume":"38","author":"Ishrat","year":"2013","journal-title":"Neurochem. Res."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3171\/2016.8.JNS16240","article-title":"Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats","volume":"127","author":"Nakazaki","year":"2017","journal-title":"J. Neurosurg."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/ene.13403","article-title":"Minocycline and matrix metalloproteinase inhibition in acute intracerebral hemorrhage: A pilot study","volume":"24","author":"Chang","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/acn3.492","article-title":"Minocycline protects against delayed cerebral ischemia after subarachnoid hemorrhage via matrix metalloproteinase-9 inhibition","volume":"4","author":"Vellimana","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/4\/3628\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:31:26Z","timestamp":1760121086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/4\/3628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,11]]},"references-count":217,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24043628"],"URL":"https:\/\/doi.org\/10.3390\/ijms24043628","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,11]]}}}